Medical Devices; TMS Therapy
Total Trials
36
As Lead Sponsor
20
As Collaborator
16
Total Enrollment
185,927
NCT00104611
Study of a Repetitive Transcranial Magnetic Stimulation (rTMS) Device for the Treatment of Major Depressive Disorder
Phase: Phase 3
Role: Lead Sponsor
Start: Jan 31, 2004
Completion: Nov 30, 2005
NCT00315367
A fMRI(Functional Magnetic Resonance Imaging) Research Study to Learn More About Multiple Sclerosis and Individuals Potentially Experiencing Memory Difficulties
Phase: Phase 4
Start: Sep 30, 2004
Completion: Oct 31, 2007
NCT00398528
An fMRI Study of Treatment Optimization Comparing Two Disease Modifying Therapies Used to Treat Relapsing Remitting Multiple Sclerosis
Phase: N/A
Start: Sep 30, 2006
Completion: Nov 30, 2007
NCT00447096
rTMS for Treatment of Depressed Phase of Bipolar Disorder Type II
Phase: Phase 2
Role: Collaborator
Start: Feb 28, 2007
Completion: Feb 28, 2010
NCT05541302
Retrospective TMS Therapy for Adults With MDD
Start: Nov 1, 2008
Completion: Aug 31, 2022
NCT01114477
NeuroStar TMS Therapy System: Utilization and Outcomes
Start: Mar 31, 2010
Completion: Sep 30, 2012
NCT01115699
Study of Repetitive Transcranial Magnetic Stimulation (rTMS) as Adjuvant Treatment for Depression
Start: Apr 30, 2010
Completion: Mar 31, 2012
NCT02466230
Antidepressant Mechanisms of Transcranial Magnetic Stimulation
Start: Jan 31, 2011
Completion: Oct 31, 2013
NCT01415154
Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients With Major Depressive Disorder
Start: Aug 31, 2011
Completion: Jul 31, 2014
NCT01659736
Transcranial Magnetic Stimulation Treatment for Generalized Anxiety Disorder
Start: May 31, 2012
Completion: Dec 31, 2014
NCT01718730
Cortical Excitability and Inhibition in MDD
Start: Oct 31, 2012
Completion: Aug 31, 2019
NCT01701284
Repetitive Transcranial Magnetic Stimulation in Cancer Patients With Depression and Anxiety
Start: Dec 31, 2012
Completion: May 31, 2023
NCT01900314
Imaging Biomarkers for TMS Treatment of Depression
Start: Sep 30, 2013
Completion: Apr 30, 2016
NCT01842542
Efficacy and Safety Study of NeuroStar TMS Therapy in Patients With Major Depressive Disorder With Postpartum Onset
Start: Dec 31, 2013
Completion: Aug 31, 2015
NCT02131129
rTMS in First Episode Psychosis
Start: Apr 30, 2014
Completion: Dec 31, 2016
NCT01815099
Start: May 31, 2014
NCT02236767
Transcranial Magnetic Stimulation Treatment of Hoarding Disorder
Start: Jul 31, 2014
NCT02273063
rTMS for PTSD Comorbid With Major Depressive Disorder
Start: Oct 31, 2014
Completion: Apr 22, 2016
NCT02521480
Determination of Analgesic Effect From One Transcranial Magnetic Stimulation(TMS)Treatment Following Vaginal Reconstructive Surgery.
Start: Jul 31, 2015
NCT02441985
rTMS Therapy for Primary Orthostatic Tremor
Start: Aug 31, 2015
Completion: Jan 8, 2019
NCT02586688
Safety and Effectiveness of NeuroStar® Transcranial Magnetic Stimulation (TMS) Therapy in Depressed Adolescents
Start: Oct 31, 2015
Completion: Dec 31, 2018
NCT02542839
rTMS and Botulinum Toxin in Primary Cervical Dystonia
Start: Nov 30, 2015
Completion: Jun 28, 2021
NCT03363919
Biomarkers in Repetitive Transcranial Magnetic Stimulation (rTMS) for Adolescent Depression
Start: Sep 24, 2018
Completion: Mar 3, 2023
NCT05384782
Computational Decision Support in Epilepsy Using Retrospective EEG
Start: Dec 1, 2019
Completion: Mar 31, 2022
NCT04217837
Treatment of Major Depressive Disorder in the UK Using TMS Therapy
Start: Mar 31, 2020
Completion: Feb 28, 2022
NCT05535062
Study to Evaluate Treatment Effects Associated With the NeuroStar SoftStart Treatment Feature
Start: Nov 7, 2022
Completion: Sep 27, 2023
NCT06699940
A Retrospective Study to Evaluate NeuroStar® Advanced Therapy in Adolescents
Start: May 1, 2023
Completion: May 1, 2023
NCT05764252
A Prospective Diagnostic Belief Updating Study to verIfy the Utility of BioEP in First Seizure Clinics.
Start: Aug 23, 2023
Completion: Sep 30, 2025
NCT06429748
Symptom Evaluation Following Repetitive Transcranial Magnetic Stimulation
Start: May 15, 2024
Completion: Dec 30, 2027
NCT06097195
The Clinical Utility of BioEP in Diagnostic Decision Making in Epilepsy
Start: May 21, 2024
Completion: Jul 1, 2027
NCT06354868
A Study to Assess utiLity of BIoEP as an Early Prognostic Indicator for Predicting Anti-Seizure Medication (ASM) Efficacy
Start: Sep 30, 2024
Completion: Jun 30, 2027
NCT06546410
OASIS: RetrOspective Analysis on EEGs for Identifying Seizure Susceptibility in paediatrIcs Using biomarkerS
Start: Jan 1, 2025
Completion: Jan 1, 2026
NCT06669364
A Retrospective Study to Validate BioEP as an Assessment Aid for Seizure Susceptibility
Completion: Mar 1, 2025
NCT06917339
Retrospective Analyses of TrakStar Database
Start: Feb 25, 2025
Completion: Dec 31, 2035
NCT06997549
Retrospective Analyses of the Greenbrook Database Evaluating Mental Health Treatments
Start: May 15, 2025
NCT07147218
Accelerated TMS for MDD
Start: Aug 21, 2025
Completion: Dec 31, 2027
Loading map...